Literature DB >> 23729583

Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice.

G Y Li1, J Z Liu, B Zhang, M Yang, S G Chen, M Hou, L X Wang.   

Abstract

PURPOSE: To evaluate the effect of Haishengsu (HSS), a protein extract from Tegillarca granosa, on multidrug-resistance genes mdr1, BCR/ABL and sorcin in transplanted tumors. MATERIAL/
METHODS: Mice were inoculated subcutaneously with a drug resistant leukemia cell line K562/ADM. Tumor-bearing animals were divided into control, adriamycin, HSS and combination therapy (adriamycin plus HSS) groups. Flow cytometry was used to detect apoptosis of tumor cells, and RT-PCR was used to evaluate the expression of mdr1, BCR/ABL and sorcin.
RESULTS: The apoptosis rate in the high (71.8%), medium (72.3%) and low doses HSS group (72.4%) was higher than in control (1.2%, p<0.01), adriamycin (34.4%, p<0.05) or combination therapy group (46.4%, p<0.05). The mean optical density of mdr1, BCR/ABL and sorcin in HSS groups was lower than in control, adriamycin and combination therapy group (p<0.01). The optical density of the three genes in high HSS group was lower than in medium and low HSS group (p<0.01).
CONCLUSIONS: Haishengsu promotes apoptosis of drug-resistant K562/ADM tumors in mice in a dose-dependent manner. The pro-apoptotic effect of Haishengsu may be related to a reduced expression of multidrug-resistance genes mdr1, BCR/ABL and sorcin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23729583     DOI: 10.2478/v10039-012-0069-8

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  6 in total

1.  The impact of Tegillarca granosa extract haishengsu on HL-60 cell.

Authors:  Jinshen Wang; Lixia Wei; Yueqin Han; Daogang Qin; Qiaozhi Yang; Xiuli Ju
Journal:  Open Med (Wars)       Date:  2015-08-03

Review 2.  Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.

Authors:  Kodappully S Siveen; Kirti S Prabhu; Iman W Achkar; Shilpa Kuttikrishnan; Sunitha Shyam; Abdul Q Khan; Maysaloun Merhi; Said Dermime; Shahab Uddin
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

Review 3.  Sorcin a Potential Molecular Target for Cancer Therapy.

Authors:  Bano Shabnam; Ganesan Padmavathi; Kishore Banik; Sosmitha Girisa; Javadi Monisha; Gautam Sethi; Lu Fan; Lingzhi Wang; Xinliang Mao; Ajaikumar B Kunnumakkara
Journal:  Transl Oncol       Date:  2018-09-11       Impact factor: 4.243

4.  Immunity-related genes and signaling pathways under hypoxic stresses in Haliotis diversicolor: a transcriptome analysis.

Authors:  Yulong Sun; Xin Zhang; Yilei Wang; Robert Day; Huiping Yang; Ziping Zhang
Journal:  Sci Rep       Date:  2019-12-24       Impact factor: 4.379

5.  Sorcin: a novel potential target in therapies of cancers.

Authors:  Xinyi Zhou; Xue Wu; Baoan Chen
Journal:  Cancer Manag Res       Date:  2019-08-05       Impact factor: 3.989

Review 6.  Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.

Authors:  Theo Battista; Annarita Fiorillo; Valerio Chiarini; Ilaria Genovese; Andrea Ilari; Gianni Colotti
Journal:  Cancers (Basel)       Date:  2020-04-06       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.